Vir Biotechnology, Inc.
Antibodies against SARS-CoV-2 and methods of using the same

Last updated:

Abstract:

The instant disclosure provides antibodies and antigen-binding fragments thereof that can bind to a SARS-CoV-2 antigen and, in certain embodiments, are capable of neutralizing a SARS-CoV-2 infection. Also provided are polynucleotides that encode an antibody or antigen-binding fragment, vectors and host cells that comprise a polynucleotide, pharmaceutical compositions, and methods of using the presently disclosed antibodies, antigen-binding fragments, polynucleotides, vectors, host cells, and compositions to treat or diagnose a SARS-CoV-2 infection.

Status:
Grant
Type:

Utility

Filling date:

25 Feb 2021

Issue date:

9 Nov 2021